In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche/Chugai Blaze a Trail...But Will Anyone Follow?

Executive Summary

Roche and Chugai have entered new dealmaking territory. This is the first time a Western company has taken over a Japanese counterpart in one go, and on a friendly basis. The deal grants Chugai enough independence for it to save face, while allowing Roche to leapfrog into the top ten in Japan. As such, the deal should in theory provide a template for others. But in Japan few CEOs are as open-minded as Chugai's leader. Equally, few Western companies can boast Roche's aptitude for arm's-length management.
Advertisement

Related Content

The Rise Of Japanese Pharma Dealmakers
The Rise Of Japanese Pharma Dealmakers
Yamanouchi/Fujisawa Merger: Closing Japanese Options
Roche's Partners: Replacing, or Fuelling In-House R&D?
Trends in Japanese Alliances
Trends in Japanese Alliances
Merck/Banyu: A Harbinger of More Western-Japanese Deals?
Merck/Banyu: A Harbinger of More Western-Japanese Deals?
Successful Product Launches in Japan
A Tepid Wedding, Now A Possible Divorce

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV001772

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel